Virginia Dermatology & Skin Cancer Center, PLLC

Virginia Dermatology & Skin Cancer Center, PLLC provides specialized dermatological services, including medical, surgical, and cosmetic care, focusing on patient-centered solutions for skin health and aesthetics across various demographics. Founded in 2006 and headquartered in Norfolk, US, Virginia Dermatology & Skin Cancer Center delivers comprehensive dermatological care. The center was acquired by Anne Arundel Dermatology Management LLC in July 2018, but specific financial terms of the deal were not disclosed. The founder's detailed history is currently not available.

Virginia Dermatology & Skin Cancer Center specializes in a comprehensive array of dermatological services that encompass medical, surgical, and cosmetic care. Their primary offerings include general and pediatric dermatology, surgical removal of skin tumors and growths, and advanced cosmetic treatments such as laser therapies, body sculpting, neurotoxin injections, and dermal fillers. The center aims to address a wide range of skin health concerns, from common issues to complex skin cancers, effectively serving individuals of all ages in the southeastern Virginia market, including Norfolk, Suffolk, and Newport News. The revenue model of Virginia Dermatology & Skin Cancer Center is based on direct-to-consumer transactions, where patients pay for medical consultations, surgical procedures, and cosmetic treatments at the time of service.

The financial structure supports a diverse client base that includes both general patients seeking dermatological assistance and those interested in cosmetic enhancements, contributing to a steady revenue flow through various procedures. Following its acquisition in July 2018, Virginia Dermatology & Skin Cancer Center is expected to leverage the resources of Anne Arundel Dermatology Management LLC for future growth. The center plans to enhance its service offerings and may explore new markets to expand its reach, although specific new products or geographic regions targeted for expansion have not been detailed. The recent acquisition is likely to support these initiatives, although specific plans regarding financing and product launches remain unspecified.